FDA Import Refusal 1FX-4670062-2/10002/2 — CIPLA LIMITED
The FDA refused shipment 1FX-4670062-2/10002/2 from CIPLA LIMITED (India) on Oct 8, 2026. The refused product falls under Drugs and Biologics — MONTELUKAST SODIUM (ANTI-ASTHMATIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Oct 8, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61ECL09 MONTELUKAST SODIUM (ANTI-ASTHMATIC)
- Charges
- 75